Yabao Pharmaceutical Group Co Ltd (600351) — Net Asset Quality Index
Yabao Pharmaceutical Group Co Ltd (600351) has a Net Asset Quality Index of 82.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.34 Billion minus total liabilities of CN¥585.77 Million yields net assets of CN¥2.76 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Yabao Pharmaceutical Group Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Yabao Pharmaceutical Group Co Ltd Net Asset Quality Index Over Time (1999–2024)
This chart shows how Yabao Pharmaceutical Group Co Ltd's Net Asset Quality Index has evolved across 26 annual periods from 1999 to 2024. As of September 2025, the index stands at 82.5%, representing net assets of CN¥2.76 Billion against total assets of CN¥3.34 Billion CNY. See how liquid is Yabao Pharmaceutical Group Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Yabao Pharmaceutical Group Co Ltd (1999–2024)
The table below presents the year-by-year Net Asset Quality Index for Yabao Pharmaceutical Group Co Ltd from 1999 to 2024, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Yabao Pharmaceutical Group Co Ltd market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 81.7% | CN¥2.89 Billion | CN¥3.54 Billion | CN¥649.02 Million | ▲ +4.0 pp |
| 2023 | 77.7% | CN¥2.99 Billion | CN¥3.85 Billion | CN¥860.33 Million | ▲ +4.9 pp |
| 2022 | 72.8% | CN¥3.01 Billion | CN¥4.13 Billion | CN¥1.12 Billion | ▲ +0.1 pp |
| 2021 | 72.7% | CN¥2.96 Billion | CN¥4.08 Billion | CN¥1.11 Billion | ▲ +2.5 pp |
| 2020 | 70.2% | CN¥2.82 Billion | CN¥4.01 Billion | CN¥1.20 Billion | ▲ +7.0 pp |
| 2019 | 63.2% | CN¥2.72 Billion | CN¥4.31 Billion | CN¥1.59 Billion | ▲ +0.7 pp |
| 2018 | 62.4% | CN¥3.01 Billion | CN¥4.83 Billion | CN¥1.81 Billion | ▼ -4.3 pp |
| 2017 | 66.7% | CN¥2.91 Billion | CN¥4.37 Billion | CN¥1.45 Billion | ▲ +1.8 pp |
| 2016 | 64.9% | CN¥2.73 Billion | CN¥4.21 Billion | CN¥1.48 Billion | ▲ +1.9 pp |
| 2015 | 63.0% | CN¥2.68 Billion | CN¥4.25 Billion | CN¥1.57 Billion | ▲ +5.8 pp |
| 2014 | 57.1% | CN¥1.82 Billion | CN¥3.18 Billion | CN¥1.37 Billion | ▲ +4.2 pp |
| 2013 | 53.0% | CN¥1.70 Billion | CN¥3.20 Billion | CN¥1.51 Billion | ▼ -3.0 pp |
| 2012 | 56.0% | CN¥1.62 Billion | CN¥2.88 Billion | CN¥1.27 Billion | ▲ +5.0 pp |
| 2011 | 51.0% | CN¥1.16 Billion | CN¥2.27 Billion | CN¥1.11 Billion | ▲ +9.8 pp |
| 2010 | 41.2% | CN¥1.00 Billion | CN¥2.43 Billion | CN¥1.43 Billion | ▲ +0.5 pp |
| 2009 | 40.7% | CN¥899.55 Million | CN¥2.21 Billion | CN¥1.31 Billion | ▼ -8.9 pp |
| 2008 | 49.6% | CN¥830.32 Million | CN¥1.67 Billion | CN¥843.93 Million | ▲ +14.2 pp |
| 2007 | 35.4% | CN¥380.08 Million | CN¥1.07 Billion | CN¥694.23 Million | ▲ +2.3 pp |
| 2006 | 33.1% | CN¥334.54 Million | CN¥1.01 Billion | CN¥675.74 Million | ▲ +1.9 pp |
| 2005 | 31.2% | CN¥354.37 Million | CN¥1.13 Billion | CN¥780.42 Million | ▼ -4.8 pp |
| 2004 | 36.1% | CN¥338.16 Million | CN¥937.81 Million | CN¥599.65 Million | ▼ -11.8 pp |
| 2003 | 47.9% | CN¥318.26 Million | CN¥664.93 Million | CN¥346.67 Million | ▼ -14.2 pp |
| 2002 | 62.1% | CN¥277.81 Million | CN¥447.38 Million | CN¥169.57 Million | ▲ +27.0 pp |
| 2001 | 35.1% | CN¥91.84 Million | CN¥261.43 Million | CN¥169.58 Million | ▼ -3.6 pp |
| 2000 | 38.7% | CN¥85.64 Million | CN¥221.07 Million | CN¥135.42 Million | ▼ -1.4 pp |
| 1999 | 40.1% | CN¥77.61 Million | CN¥193.41 Million | CN¥115.80 Million | — |